ArticleOncotarget2017
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma.
Emily Capone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleOncotarget2017
Emily Capone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.